1. Academic Validation
  2. The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin ⍺4β7

The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin ⍺4β7

  • PLoS Pathog. 2023 Dec 8;19(12):e1011860. doi: 10.1371/journal.ppat.1011860.
Donald Van Ryk 1 Sinmanus Vimonpatranon 1 2 Joe Hiatt 1 Sundar Ganesan 3 Nathalie Chen 1 Jordan McMurry 1 Saadiq Garba 1 Susie Min 1 Livia R Goes 1 4 Alexandre Girard 1 Jason Yolitz 1 Isabella Licavoli 1 Danlan Wei 1 Dawei Huang 5 Marcelo A Soares 4 6 Elena Martinelli 7 Claudia Cicala 1 James Arthos 1
Affiliations

Affiliations

  • 1 Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
  • 2 Department of Retrovirology, Armed Forces Research Institute of Medical Sciences-United States Component, Bangkok, Thailand.
  • 3 Biological Imaging Section, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
  • 4 Oncovirology Program, Instituto Nacional de Câncer, Rio de Janeiro, Rio de Janeiro, Brazil.
  • 5 Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, United States of America.
  • 6 Department of Genetics, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • 7 Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
Abstract

The CD4 receptor, by stabilizing TCR-MHC II interactions, plays a central role in adaptive immunity. It also serves as the HIV docking receptor. The HIV gp120 envelope protein binds directly to CD4. This interaction is a prerequisite for viral entry. gp120 also binds to ⍺4β7, an Integrin that is expressed on a subset of memory CD4+ T cells. HIV tropisms for CD4+ T cells and gut tissues are central features of HIV pathogenesis. We report that CD4 binds directly to ⍺4β7 in a dynamic way, consistent with a cis regulatory interaction. The molecular details of this interaction are related to the way in which gp120 interacts with both receptors. Like MAdCAM-1 and VCAM-1, two recognized ligands of ⍺4β7, the binding interface on CD4 includes 2 sites (1° and accessory), distributed across its two N-terminal IgSF domains (D1 and D2). The 1° site includes a sequence in the G β-strand of CD4 D2, KIDIV, that binds directly to ⍺4β7. This pentapeptide sequence occurs infrequently in eukaryotic proteins. However, a closely related and conserved sequence, KLDIV, appears in the V2 domain of gp120. KLDIV mediates gp120-⍺4β7 binding. The accessory ⍺4β7 binding site on CD4 includes Phe43. The Phe43 aromatic ring protrudes outward from one edge of a loop connecting the C'C" strands of CD4 D1. Phe43 is a principal contact for HIV gp120. It interacts with conserved residues in the recessed CD4 binding pocket. Substitution of Phe43 abrogates CD4 binding to both gp120 and ⍺4β7. As such, the interactions of gp120 with both CD4 and ⍺4β7 reflect elements of their interactions with each other. These findings indicate that gp120 specificities for CD4 and ⍺4β7 are interrelated and suggest that selective pressures which produced a CD4 tropic virus that replicates in gut tissues are linked to a dynamic interaction between these two receptors.

Figures
Products